Authors:
Schellens, JHM
Dombernowsky, P
Cassidy, J
Epelbaum, R
Dirix, L
Cox, EH
Wanders, J
Calabresi, F
Paridaens, R
Monfardini, S
Wolff, J
Loos, WJ
Verweij, J
Pavlidis, N
Hanauske, AR
Citation: Jhm. Schellens et al., Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9, ANTI-CANC D, 12(7), 2001, pp. 583-590
Authors:
Cox, EH
Veyrat-Follet, C
Beal, SL
Fuseau, E
Kenkare, S
Sheiner, LB
Citation: Eh. Cox et al., A population pharmacokinetic-pharmacodynamic analysis of repeated measurestime-to-event pharmacodynamic responses: The antiemetic effect of ondansetron, J PHAR BIOP, 27(6), 1999, pp. 625-644
Authors:
Cox, EH
Langemeijer, MWE
Gubbens-Stibbe, JM
Muir, KT
Danhof, M
Citation: Eh. Cox et al., The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model, ANESTHESIOL, 90(2), 1999, pp. 535-544